MacroHealth USA

MacroHealth USA is a healthcare technology firm providing an Intelligent Health Market as a Service (IHMaaS) platform that streamlines healthcare purchasing for Payers and Health Market Partners through enhanced data analytics and price transparency. MacroHealth USA specializes in optimizing healthcare purchasing solutions. Founded in 2017 by Darren Plotkin, Glenn Plotkin, and Shaun Plotkin, the company is headquartered in Kirkland, US. It received investment from NewSpring Capital and TT Capital Partners in June 2020, although the financial terms were not disclosed.

The company has completed one deal as of mid-2020. MacroHealth operates primarily through its Intelligent Health Market as a Service (IHMaaS) platform, which provides a comprehensive marketplace solution aimed at optimizing healthcare purchasing for various stakeholders, including Payers and Health Market Partners. The platform integrates multiple functionalities such as provider networks, specialty networks, out-of-network repricing solutions, and contract repricing solutions, facilitating seamless connections across the healthcare ecosystem. This service aims to reduce healthcare costs, improve operational efficiency, and enhance decision-making capabilities through real-time data analytics and price transparency.

MacroHealth's clientele includes health insurance providers, third-party administrators, and employers, who utilize the platform to navigate the complexities of healthcare offerings effectively. The IHMaaS solution is marketed across the United States and Canada, targeting the growing demand for efficient healthcare management solutions. MacroHealth generates revenue through partnerships and subscription-based models, wherein clients pay for access to the IHMaaS platform and its various features. Clients may engage in transactions that involve using the platform to connect with a network of healthcare providers, driving operational efficiencies and cost savings through enhanced analytics and automation.

The structure of these transactions typically includes ongoing service fees, which may vary based on the scale and scope of services utilized. Flagship services include the MacroHealth Intelligent Exchange (MiX)™, which offers a marketplace for Payers to optimize healthcare resource allocation. As clients increase their engagement with the platform, they benefit from actionable insights that support decision-making and strategic planning, ultimately enhancing their overall business outcomes. MacroHealth plans to leverage its recent funding from NewSpring Capital and TT Capital Partners, received in June 2020, to enhance its IHMaaS platform further and introduce new features.

The company is targeting expansion into additional markets across North America over the next two years, focusing on regions with significant healthcare service demands. Upcoming product launches are expected to deliver enhanced functionalities aimed at improving user experience and operational efficiencies for healthcare stakeholders.